TABLE 2.
Quality of cancer survivorship care framework domains
| Study | Surveillance and management of physical effects | Surveillance and management of psychosocial effects | Prevention and surveillance for recurrence and new cancers | Surveillance and management of chronic medical conditions | Health promotion and disease prevention |
|---|---|---|---|---|---|
| Alamoudi 2018 12 | ✓ | ✓ | |||
| Al‐Bazie 2016 25 | ✓ | ||||
| Bhatia 2017 13 | ✓ | ||||
| Chan 2004 26 | ✓ | ✓ | |||
| Chen 2020 27 | ✓ | ||||
| Cramer 2021 14 | ✓ | ||||
| DeLeeuw 2013 28 | ✓ | ✓ | |||
| Dholam 2011 29 | ✓ | ✓ | |||
| Fong 2014, 31 Fong 2014 30 | ✓ | ✓ | ✓ | ✓ | |
| Guglielmo 2020 15 | ✓ | ✓ | |||
| Jansen 2020 16 | ✓ | ✓ | |||
| Kaae 2020 17 | ✓ | ||||
| Kraaijenga 2017 32 | ✓ | ✓ | |||
| Liu 2021 33 | ✓ | ||||
| Manne 2020 34 | ✓ | ✓ | ✓ | ||
| Martin‐Harris 2015 35 | ✓ | ||||
| McNeely 2015 18 | ✓ | ✓ | |||
| Millgard 2020 19 | ✓ | ||||
| Montalvo 2020 36 | ✓ | ||||
| Mozzati 2014 37 | ✓ | ||||
| Nativ‐Zeltzer 2021 38 | ✓ | ||||
| Pauli 2016 39 | ✓ | ✓ | |||
| Pereira 2020 20 | ✓ | ✓ | |||
| Schutte 2021 21 | ✓ | ✓ | |||
| Sterba 2019 40 | ✓ | ||||
| Tang 2011 22 | ✓ | ||||
| Vadcharavivad 2013 23 | ✓ | ||||
| Wu 2019 24 | ✓ |